We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$6.14B
1-Year Est. Return
42.05%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+42.05%
3 Year Est. Return
+148.08%
5 Year Est. Return
+210.34%
10 Year Est. Return
+1,110.53%
AUM
$4.1B
AUM Growth
-$211M
(-4.9%)
Cap. Flow
-$383M
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
31.52%
Holding
170
New
36
Increased
33
Reduced
38
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Foods
USFD
|
+$90.4M |
| 2 |
Lumen
LUMN
|
+$84.5M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$80.5M |
| 4 |
Biogen
BIIB
|
+$73.6M |
| 5 |
AET
Aetna Inc
AET
|
+$71.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$99.1M |
| 2 |
CMA
Comerica
CMA
|
+$68M |
| 3 |
PVTB
PrivateBancorp Inc
PVTB
|
+$64.4M |
| 4 |
CSC
Computer Sciences
CSC
|
+$49.1M |
| 5 |
MetLife
MET
|
+$46.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.84% |
| 2 | Healthcare | 17.85% |
| 3 | Consumer Discretionary | 15.38% |
| 4 | Consumer Staples | 9.47% |
| 5 | Communication Services | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Best Buy
BBY
$19B
| $12.4M | 0.3% |
216,934
-5,448
| -2% | -$291K |
|
77
Rithm Capital
RITM
$5.63B
| $12.2M | 0.3% |
+784,100
| New | +$13M |
|
78
Humana
HUM
$48.2B
| $10.7M | 0.26% |
44,668
-151,534
| -77% | -$34.3M |
|
|
MRSH
79
Marsh
MRSH
$88.6B
| $10.6M | 0.26% |
135,800
-225,800
| -62% | -$17.1M |
|
|
SEE
80
CALL
DELISTED
Sealed Air
SEE
| $10.3M | 0.25% |
230,000
| – | – |
|
|
ALXN
81
DELISTED
Alexion Pharmaceuticals
ALXN
| $10.2M | 0.25% |
84,100
+34,800
| +71% | +$4.05M |
|
|
IPXL
82
DELISTED
Impax Laboratories, Inc.
IPXL
| $8.93M | 0.22% |
554,400
-13,600
| -2% | -$201K |
|
|
SKX
83
DELISTED
Skechers
SKX
| $8.72M | 0.21% |
+295,766
| New | +$7.64M |
|
84
PUT
Fastenal
FAST
$56.9B
| $8.71M | 0.21% |
800,000
-1,600,000
| -67% | -$18M |
|
85
Mattel
MAT
$4.15B
| $8.69M | 0.21% |
+403,710
| New | +$9.12M |
|
86
PayPal
PYPL
$47B
| $8.57M | 0.21% |
+159,735
| New | +$7.85M |
|
87
Home Depot
HD
$320B
| $8.12M | 0.2% |
+52,954
| New | +$8.12M |
|
88
Texas Roadhouse
TXRH
$12.4B
| $7.85M | 0.19% |
154,051
+17,770
| +13% | +$858K |
|
89
Steven Madden
SHOO
$3.2B
| $7.82M | 0.19% |
+293,625
| New | +$7.46M |
|
90
PUT
Gentex
GNTX
$4.88B
| $7.59M | 0.19% |
400,000
-350,000
| -47% | -$6.82M |
|
91
Essent Group
ESNT
$6.22B
| $7.05M | 0.17% |
189,800
+50,500
| +36% | +$1.85M |
|
92
American Eagle Outfitters
AEO
$2.91B
| $7M | 0.17% |
580,708
-412,780
| -42% | -$5.18M |
|
|
ITCI
93
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.67M | 0.16% |
537,200
+198,700
| +59% | +$2.3M |
|
94
Radian Group
RDN
$4.85B
| $6.42M | 0.16% |
392,500
| – | – |
|
95
lululemon athletica
LULU
$11.1B
| $6.3M | 0.15% |
+105,677
| New | +$5.5M |
|
96
Sarepta Therapeutics
SRPT
$2.38B
| $5.44M | 0.13% |
161,300
-73,000
| -31% | -$2.38M |
|
|
NVRO
97
DELISTED
NEVRO CORP.
NVRO
| $5.12M | 0.13% |
68,800
+21,609
| +46% | +$1.73M |
|
|
LL
98
DELISTED
LL Flooring Holdings, Inc.
LL
| $4.84M | 0.12% |
+193,050
| New | +$4.85M |
|
|
SAGE
99
DELISTED
Sage Therapeutics
SAGE
| $3.77M | 0.09% |
47,300
-9,400
| -17% | -$680K |
|
100
Bath & Body Works
BBWI
$3.93B
| $3.29M | 0.08% |
+75,485
| New | +$3.09M |
|
Similar funds
MF
LP
SLI
MSU
EQF
PAMP
WCM
MOS
Samlyn Capital's Q2 2017 Portfolio in Review
As of Q2 2017, Samlyn Capital held 170 positions worth $4.1B, down 4.9% from $4.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Samlyn Capital withdrew a net $383M in Q2 2017, closing 60 positions and reducing 38 holdings. Its most notable exit was Aramark, an estimated $99.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Samlyn Capital opened a new position in Lumen worth $80.3M.
- Samlyn Capital's largest Q2 2017 buy was Lumen: 3,362,246 shares worth $80.3M.
- Samlyn Capital added most to US Foods in Q2 2017, an estimated $90.4M increase.
- Samlyn Capital's biggest Q2 2017 reduction was UnitedHealth, cutting an estimated $42.1M.
- Samlyn Capital fully exited Aramark in Q2 2017, selling an estimated $99.1M.
- Samlyn Capital's ten largest holdings make up 32% of its $4.1B portfolio in Q2 2017.
- Samlyn Capital opened 36 new positions and closed 60 in Q2 2017.
- Samlyn Capital's portfolio value fell 4.9% quarter-over-quarter to $4.1B.
Based on Samlyn Capital's 13F filing for Q2 2017, filed 14 Aug 2017.